1044277-06-6

Basic information

• Product Name: 4-(3-fluorophenyl)-7-methyl-2H-chromen-2-one
• Synonyms: 4-(3-fluorophenyl)-7-methyl-2H-chromen-2-one;2H-1-Benzopyran-2-one, 4-(3-fluorophenyl)-7-methyl-
• CAS NO: 1044277-06-6
• Molecular Formula: C₁₆H₁₁FO₂
• Molecular Weight: 254.2557432
• Mol File: 1044277-06-6.mol

Chemical Properties

• Appearance: /
• Density: 1.272
• CAS DataBase Reference: 4-(3-fluorophenyl)-7-methyl-2H-chromen-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-fluorophenyl)-7-methyl-2H-chromen-2-one(1044277-06-6)
• EPA Substance Registry System: 4-(3-fluorophenyl)-7-methyl-2H-chromen-2-one(1044277-06-6)

Safety Data

• Hazardous Substances Data: 1044277-06-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-(3-fluorophenyl)-7-methyl-2H-chromen-2-one is used as a pharmaceutical candidate for its potential antioxidant, anti-inflammatory, and anticancer properties. Its unique chemical structure and biological activities make it a promising candidate for the development of new drugs and therapies.
Used in Medical Research:
In the field of medical research, 4-(3-fluorophenyl)-7-methyl-2H-chromen-2-one is utilized for studying its potential biological activities and exploring its efficacy in treating various diseases and conditions, particularly those related to oxidative stress, inflammation, and cancer.

Upstream product

• 861577-00-6 C₁₂H₁₄O₃ 
• 1426251-76-4 bis(3-fluorophenyl)iodonium tetrafluoroborate 
• 455-38-9 3-fluorobenzoic acid 
• 122-46-3 3-acetoxytoluene 
• 6921-64-8 4'-hydroxy-2'-methylacetophenone 
• 33166-77-7 ethyl 3-(3-fluorophenyl)-3-oxopropanoate 
• 108-39-4 3-methyl-phenol 
• 167840-97-3 7-Methylcoumarin-4-yl trifluoromethanesulfonate 
• 768-35-4 3-fluorophenylboronic acid 

Downstream Products

• 1044277-07-7 7-(bromomethyl)-4-(3-fluorophenyl)-2H-chromen-2-one 
• 1044277-08-8 7-(azidomethyl)-4-(3-fluorophenyl)-2H-chromen-2-one 
• 1044277-09-9 (1S)-1-(1-{[4-(3-fluorophenyl)-2-oxo-2H-chromen-7-yl]-methyl}-1H-1,2,3-triazol-4-yl)-1-(trifluoromethyl)propyl 4-nitrobenzoate 
• 1044277-01-1 (1S)-1-(1-{[4-(3-fluorophenyl)-2-oxo-2H-chromen-7-yl]-methyl}-1H-1,2,3-triazol-4-yl)-1-(trifluoromethyl)propyl 4-nitrobenzoate 

Relevant articles and documents

Synthesis of 4-arylcoumarins via palladium-catalyzed arylation/cyclization of ortho-hydroxylcinnamates with diaryliodonium salts

The palladium-catalyzed arylation/cyclization of ortho-hydroxylcinnamate ester derivatives by using diaryliodonium(III) salts has been developed. With this method, 4-arylcoumarins were easily prepared in good to excellent yields under base-free conditions

Convergent, fit-for-purpose, kilogram-scale synthesis of a 5-lipoxygenase inhibitor

Process research and development of a synthetic route towards a novel 5-lipoxygenase inhibitor is described. The synthetic route provided 1 in 27% yield in nine steps (seven steps in the longest linear sequence) and was performed on kilogram scale. The synthesis began with the preparation of the coumarin core via an efficient von Pechmann condensation. The triazole fragment was obtained via a regioselective copper-catalyzed [3 + 2] cycloaddition between a chiral alkyne and the coumarin azide.

Novel pharmaceutical compounds

The instant invention provides compounds of Formula I which are leukotriene biosynthesis inhibitors. Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.